Church & Dwight Q4 sales rise 3.5%, adjusted EPS $0.77; 2025 EPS growth outlook 7-8%
Church & Dwight reported fourth-quarter 2024 net sales of $1,582.0 million, up 3.5%, and adjusted EPS of $0.77, up 18.5%, both ahead of its outlook. Full-year reported EPS fell 22.3% to $2.37 because of $357.1 million in asset impairments, mainly in its vitamin business, while full-year adjusted EPS rose 8.5% to $3.44. The company also expects 2025 adjusted EPS to grow 7% to 8% and raised its quarterly dividend 4%, but guided first-quarter adjusted EPS down 6% to $0.90.
Key points
- Q4 2024 net sales $1,582.0 million, up 3.5%; organic sales up 4.2%, above the 2% to 3% outlook
- Q4 reported EPS $0.76, up 22.6%; adjusted EPS $0.77 versus $0.65 a year earlier
- Full-year reported EPS $2.37, down 22.3%, due to $357.1 million in tradename and asset impairments
- Quarterly dividend raised 4% to $0.295 per share, payable March 3, 2025
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.